Browse > Article
http://dx.doi.org/10.22722/KJPM.2020.28.1.36

A Retrospective Study on the Effect of 1-Year Clozapine Administration on Platelet Activity in Patients with Schizophrenia or Schizoaffective Disorder  

Jang, EunJa (Department of Psychiatry, College of Medicine, Konyang University)
Lee, Jong Wook (Konyang University Myunggok Medical Research Institute)
Kim, Seung-Jun (Department of Psychiatry, College of Medicine, Konyang University)
Oh, Hong-Seok (Department of Psychiatry, College of Medicine, Konyang University)
Im, Woo Young (Department of Psychiatry, College of Medicine, Konyang University)
Lee, Na-Hyun (Department of Psychiatry, College of Medicine, Konyang University)
Kim, Ji-Woong (Department of Psychiatry, College of Medicine, Konyang University)
Publication Information
Korean Journal of Psychosomatic Medicine / v.28, no.1, 2020 , pp. 36-41 More about this Journal
Abstract
Objectives : Clozapine has been known to increase the possibility of developing cardio/cerebrovascular diseases, and the platelet activation has been deemed to be related to the occurrence of them. In author's previous study, we observed the increase of platelet activity with short-term clozapine administration. This study was conducted, as a follow-up study, to investigate the effect of clozapine on the platelet activity when administered continuously for long-term period of time of 1 year. Methods : The medical records of the patients with schizophrenia or schizoaffective disorder who were treated with clozapine for 1 year were retrospectively reviewed. The degree of platelet activation was assessed by measuring the mean platelet component. Results : Total of 24 patients were enrolled. 9 of them (37.5%) were male and 15 of them (62.5%) were female. In the Wilcoxon sign-ranks test, no significant change was observed between the mean platelet factor values at the beginning and at the end of one year. Conclusions : No significant changes of mean platelet activity were observed after continued administration of clozapine for 1 year. Considering the author's previous findings that observed a prominent decrease of mean platelet component after short-term clozapine administration, the result of this study suggests the possibility that the activity of the platelet may change depending on the duration of the clozapine administration.
Keywords
Clozapine; Mean platelet component; Platelet activation; Metabolic side effects; Thromboembolic disease;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lund BC, Perry PJ, Brooks JM, Arndt S. Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach. Arch Gen Psychiatry 2001;58:1172-1176.   DOI
2 Poudyal R, Lohani S. Clozapine associated pulmonary embolism: systematic review. J Community Hosp Intern Med Perspect 2019;9:300-304.   DOI
3 Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ 2010;341:c4245.   DOI
4 Kim HA, Lee JW, Kim SJ, Oh HS, Im WY, Kim JW. Second-generation antipsychotics activate platelets in antipsychotic-naive and antipsychotic-free patients with schizophrenia: a retrospective study. Int J Psychiatry Med 2020;55:105-113.   DOI
5 Chapman ES, Sorette M, Hetherington E, Zelmanovic D, Dugailliez J, Pujol-Moix N, Okrongly D. A rapid, automated flow cytometric method to measure activated degranulated platelets by density determination. Thromb Haemost 2003;89:1004-1015.   DOI
6 Macey MG, Carty E, Webb L, Champman ES, Zelmanovic D, Rampton DS, Newland AC. Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system. Cytometry 1999;38:250-255.   DOI
7 Lee J, Takeuchi H, Fervaha G, Powell V, Bhaloo A, Bies R, Remington G. The effect of clozapine on hematological indices: a 1-year follow-up study. J Clin Psychopharmacol 2015;35:510-516.   DOI
8 Sarvaiya N, Lapitskaya Y, Dima L, Manu P. Clozapine-associated pulmonary embolism: a high-mortality, dose-independent and early-onset adverse effect. Am J Ther 2018;25:e434-e438.   DOI
9 Dietrich-Muszalska A, Wachowicz B. Platelet haemostatic function in psychiatric disorders: effects of antidepressants and antipsychotic drugs. World J Biol Psychiatry 2017;18:564-574.   DOI
10 Leysen JE, de Chaffoy de Courcelles D, De Clerck F, Niemegeers CJ, Van Nueten JM. Serotonin-S2 receptor binding sites and functional correlates. Neuropharmacology 1984;23:1493-1501.   DOI
11 Zahorodna A, Bobula B, Grzegorzewska M, Tokarski K, Hess G. The influence of repeated administration of clozapine and haloperidol on the effects of the activation of 5-HT(1A), 5-HT(2) and 5-HT(4) receptors in rat frontal cortex. J Physiol Pharmacol 2004;55:371-379.
12 Bae SH, Lee J, Roh KH, Kim J. Platelet activation in patients with diabetic retinopathy. Korean J Ophthalmol 2003;17:140-144.   DOI
13 Masopust J, Maly R, Valis M. Risk of venous thromboembolism during treatment with antipsychotic agents. Psychiatry Clin Neurosci 2012;66:541-552.   DOI
14 Sertbas Y, Sertbas M, Okuroglu N, Ozturk MA, Abacar KY, Ozdemir A. Mean platelet volume changes before and after glycated hemoglobin (HbA1c) improvement in a large study population. Arch Med Sci 2017;13:711-715.
15 Agrawal J, Singh VB, Meena B, Yadav R, Shareef M, Saini V. Mean platelet volume (MPV) the neglected marker of cardiovascular risk and glycosylated hemoglobin in diabetic patient. Diabetes Metab Syndr 2017;11:109-112.   DOI
16 Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010;8:148-156.   DOI
17 Kasckow J, Felmet K, Zisook S. Managing suicide risk in patients with schizophrenia. CNS Drugs 2011;25:129-143   DOI